3/19/25 18:44 | 3/17/25 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Marshall Robert J. Jr. | MA | O | CFO,Trea | 1 | S | -1,005 | 100.52 | 0 | -10 | | 114 | D | | | | | | | | | | | | | | |
3/17/25 20:09 | 6/7/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | D | | 2 | S.m | -5,011 | 94.35 | 0 | -53 | | 608 | I | | | | | | | | | | | | | | |
3/7/25 17:44 | 3/5/25 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Blanchfield Paul | MA | O | P | 1 | S.d | -204 | 98.00 | 0 | -2 | | 119 | D | | | | | | | | | | | | | | |
3/4/25 16:43 | 3/4/25 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Clark Eliana | MA | O | EVP,Chie | 2 | S.dm | -103 | 11.92 | 0 | -9 | | 95 | D | | | | | | | | | | | | | | |
3/4/25 16:21 | 3/4/25 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Basta James | MA | O | EVP,GC | 2 | S.d | -109 | 11.33 | 0 | -10 | | 112 | D | | | | | | | | | | | | | | |
2/11/25 17:00 | 2/10/25 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Fennell George | ME | O | EVP | 1 | S.d | -4,619 | 462.53 | 0 | -10 | | 8 | D | | | | | | | | | | | | | | |
2/3/25 19:26 | 1/31/25 | IONS | Ionis Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hougen Elizabeth L | CA | O | EVP,Fina | 2 | S.d | -340 | 32.75 | 0 | -10 | | 111 | D | | | | | | | | | | | | | | |
1/31/25 16:17 | 1/29/25 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bhanji Muna | MA | D | | 1 | S | -3 | 9.97 | 0 | 0 | | 19 | D | | | | | | | | | | | | | | |
1/17/25 16:15 | 1/15/25 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Thrall James H | MA | D | | 1 | S | -95 | 94.76 | 0 | -1 | | 33 | D | | | | | | | | | | | | | | |
1/7/25 17:23 | 1/3/25 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Dube Michael P | MA | O | VP,Chief | 1 | S | -17 | 12.18 | 0 | -1 | | 46 | D | | | | | | | | | | | | | | |
1/7/25 17:20 | 1/3/25 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lebwohl David | MA | O | EVP,Chie | 1 | S | -116 | 12.18 | 0 | -10 | | 88 | D | | | | | | | | | | | | | | |
1/7/25 17:20 | 1/3/25 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hicks Derek | MA | O | EVP,Chie | 1 | S | -79 | 12.18 | 0 | -7 | | 60 | D | | | | | | | | | | | | | | |
1/7/25 17:19 | 1/3/25 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M | MA | DO | P,CEO | 1 | S | -327 | 12.18 | 0 | -27 | | 1,000 | D | | | | | | | | | | | | | | |
1/7/25 17:16 | 1/3/25 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sepp-Lorenzino Laura | MA | O | EVP,Chie | 1 | S | -109 | 12.18 | 0 | -9 | | 77 | D | | | | | | | | | | | | | | |